Regensburg, Germany – May 9, 2025 – Lifespin GmbH, a leader in personalized healthcare innovation, together with Hochschule Weihenstephan-Triesdorf (HSWT), is pleased to announce the receipt of a distinguished grant from the Bayerische Forschungsstiftung for their groundbreaking project, Deep Health: The Next Generation of Personalized Diagnostics with AI and NMR. This significant funding affirms the project’s potential to redefine precision medicine and solidifies the leadership of Lifespin and HSWT in AI-driven health advancements.
The Deep Health initiative integrates the precision of nuclear magnetic resonance (NMR) spectroscopy with state-of-the-art artificial intelligence to develop an advanced AI foundation model. This model is engineered to interpret the complex patterns within NMR spectra derived from human blood samples, delivering profound insights into individual metabolic profiles. Utilizing self-supervised learning and transformer architectures, Deep Health will enable the accurate identification of health conditions and disease risks, fostering enhanced prevention, early detection, and personalized treatment strategies.
“This grant underscores the strategic collaboration between Lifespin’s expertise in NMR-based metabolomics and HSWT’s renowned proficiency in AI and bioengineering,” stated Dr. Roland Geyer, Chief Operating Officer at Lifespin GmbH. “Deep Health marks a significant advancement in personalized diagnostics, equipping clinicians and researchers with the tools to harness metabolomic data for superior health outcomes.”
The project employs an innovative methodology, incorporating synthetic NMR spectra and a robust fine-tuning framework, to establish new benchmarks in diagnostic scalability and adaptability. Over a three-year timeline, Deep Health will produce prototype applications for substance quantification, sample quality assessment, and comprehensive health evaluation, laying the groundwork for future commercial solutions that address critical needs in clinical diagnostics and health monitoring.
Prof. Dr. Andreas Krumpel of HSWT remarked, “This partnership exemplifies the strength of interdisciplinary collaboration. By uniting advanced AI techniques with NMR technology, we are advancing scientific knowledge while reinforcing Bavaria’s position as a leader in the global life sciences landscape.”
Backed by a €1.14 million investment, Deep Health will catalyze economic and scientific progress, creating high-skill employment opportunities and fostering robust academic-industry partnerships. The project’s outcomes are poised to transform personalized medicine, delivering scalable, cost-effective solutions that elevate patient care and optimize healthcare systems worldwide.
Lifespin GmbH and HSWT express their deep appreciation to the Bayerische Forschungsstiftung for their support and shared commitment to advancing human health through innovation. As Deep Health progresses, it promises to usher in a new era of precision diagnostics, redefining how health is understood and managed.
About Lifespin GmbH: Lifespin GmbH, based in Regensburg, Germany, is a pioneer in NMR-based metabolomics, providing cutting-edge solutions for proactive health assessment. With a comprehensive database of over 250,000 metabolomic profiles and a dedication to data-driven innovation, Lifespin is shaping the future of personalized healthcare globally. For more information, visit www.lifespin.health.
About Hochschule Weihenstephan-Triesdorf (HSWT): HSWT, located in Freising, Germany, is a distinguished institution specializing in bioengineering, applied sciences, and interdisciplinary research. With a strong legacy in NMR and AI, HSWT is a vital contributor to innovation in the life sciences.
Learn more at www.hswt.de.
Media Contact:
Dr. Roland Geyer
Lifespin GmbH
Email: roland.geyer@lifespin.health
Phone: +49 941 94289815
